drugset
drugset / Trial / NCT07345390

Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 Cream in Facial Acne Vulgaris

NCT07345390 ↗

Phase 2 Not yet recruiting 180 enrolled Jiangxi Kvvit Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the safety, efficacy and pharmacokinetics of KR230109 cream compared with placebo in Patients (18-40 Years) with Acne vulgaris

Timeline

Start
2026-01-10
Primary completion
2026-10-30
Completion
2026-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject KR230109 Unknown 0.025 % Topical
Subject KR230109 Unknown 0.05 % Topical

Indications

acne